Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Friday, March 31, 2023.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2023 (2023-03-31): -262.03%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-65.37%
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tevogen Bio Holdings Inc.
Market Cap
$28.07M
Return on Equity (ROE)
N/A
TTM Avg
-65.37%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$28.08M
Return on Equity (ROE)
-65.05%
TTM Avg
-525.23%
3Y Avg
-779.21%
5Y Avg
-536.29%
Market Cap
$28.10M
Return on Equity (ROE)
-83.26%
TTM Avg
-46.97%
3Y Avg
-39.40%
5Y Avg
-27.49%
Market Cap
$28.31M
Return on Equity (ROE)
N/A
TTM Avg
78.98%
3Y Avg
134.04%
5Y Avg
114.40%
Market Cap
$27.79M
Return on Equity (ROE)
-124.64%
TTM Avg
-100.64%
3Y Avg
-80.07%
5Y Avg
-67.08%
Market Cap
$28.47M
Return on Equity (ROE)
N/A
TTM Avg
29.33%
3Y Avg
173.42%
5Y Avg
64.03%
Market Cap
$29.37M
Return on Equity (ROE)
-117.69%
TTM Avg
-1443.79%
3Y Avg
-971.02%
5Y Avg
-813.57%
Market Cap
$29.57M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$29.74M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. (TVGN) | $28.07M | N/A | -65.37% | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | -65.05% | -525.23% | -779.21% | -536.29% |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | -83.26% | -46.97% | -39.40% | -27.49% |
| OneMedNet Corporation (ONMD)vs › | $28.31M | N/A | 78.98% | 134.04% | 114.40% |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | -124.64% | -100.64% | -80.07% | -67.08% |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | N/A | 29.33% | 173.42% | 64.03% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -117.69% | -1443.79% | -971.02% | -813.57% |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | -120.40% | -43.89% | -83.08% | -65.54% |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -111.81% | -29.10% | -257.52% | 159.26% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | -116.14% | -228.74% | 113.10% | 76.03% |
ROE
N/A
ROA
-457.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2023-03-31 | -262.03% |
| 2022-09-30 | 0.52% |
| 2022-06-30 | 0.05% |
| 2022-03-31 | -0.02% |
